Bladder Urothelial Carcinoma

Bladder Urothelial Carcinoma, also known as transitional cell carcinoma of the bladder, is related to transitional cell carcinoma and bladder cancer. An important gene associated with Bladder Urothelial Carcinoma is TUG1 (Taurine Up-Regulated 1), and among its related pathways/superpathways are Gene expression (Transcription) and Infectious disease. The drugs Disitamab vedotin and Immunoconjugates have been mentioned in the context of this disorder. Affiliated tissues include lymph node and prostate, and related phenotypes are Decreased viability and Increased shRNA abundance (Z-score > 2)